TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Items tagged with Advocacy

Technical brief: Access to TB testing and treatments: GeneXpert and delamanid (post with simple image)

Médecins Sans Frontières issues a report offering case studies of two critical TB tools, GeneXpert and delamanid, and outlining actions that the corporations making them need to take to unlock access to these tools.

Report: TB Research Funding Trends 2005-2022 (post with simple image)

TB research and development funding perilously off track of UN commitments to end TB by 2030.

Addressing the needs of people with extensively drug-resistant TB through pre-approval access to drugs and research (post with simple image)

A viewpoint, published in Public Health Action, advocates for transparent, accessible pre-approval access as a core element of person-centered care for drug-resistant TB.

Stop TB Partnership announces the Legal Environment and Human Rights Scorecard (post with simple image)

The Scorecard aims to enhance visibility and multisectoral accountability regarding legal, policy and human rights barriers experienced by people affected by TB.

Statement from TAG, Global TB CAB on H56:IC31 Phase IIb trial results (post with simple image)

The Global TB CAB and TAG commend the investigators for sharing results early and openly with a diverse group of key stakeholders, and urge the scientific community and funders to continue efforts to find different options to prevent TB.

Call to Action: Shorter and more effective treatment for all people suffering from drug-resistant TB (post with simple image)

Sign up for a Call to Action for accelerating the implementation of shorter and more effective treatment for all people with drug-resistant TB.

Lindsay McKenna: What does it mean to be a good activist? (post with simple image)

At the 2023 Union Conference, TAG's Lindsay McKenna sat down with Denis Godlevsky of ITPC EECA for a wide-ranging discussion on TB research, activism, and TAG's historic + present role shaping both.

The rejection of the bedaquiline patent opposition in Indonesia raises the risk of difficulty in accessing optimal TB therapy (post with simple image)

The patent opposition was submitted by the Indonesia AIDS Coalition and Indonesia for Global Justice in November 2022 and was rejected by a decision from the Judiciary Panel on 9 November 2023.

TB advocacy resource: A Different Kind of Gap (post with simple image)

ACTON releases an advocacy tool exploring what funding gaps in the Global Fund’s Grant Cycle 7 mean for the fight against TB and what happens if they are not filled.

World TB Day 2024 campaign toolkit (post with simple image)

The Stop TB Partnership releases the campaign toolkit for this year’s 'Yes! We Can End TB' World TB Day campaign on 24 March 2024.

Page 124 of 127 · Total posts: 0

←First 123 124 125 Last→